State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers

June H. Kim, Julian Santaella-Tenorio, Christine Mauro, Julia Wrobel, Magdalena Cerda, Katherine M. Keyes, Deborah Hasin, Silvia S. Martins, Guohua Li

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

Objectives. To assess the association between medical marijuana laws (MMLs) and the odds of a positive opioid test, an indicator for prior use. Methods. We analyzed 1999-2013 Fatality Analysis Reporting System (FARS) data from 18 states that tested for alcohol and other drugs in at least 80% of drivers who died within 1 hour of crashing (n = 68 394). Within-state and between-state comparisons assessed opioid positivity among drivers crashing in states with an operational MML (i.e., allowances for home cultivation or active dispensaries) versus drivers crashing in states before a future MML was operational. Results. State-specific estimates indicated a reduction in opioid positivity for most states after implementation of an operational MML, although none of these estimates were significant. When we combined states, we observed no significant overall association (odds ratio [OR] = 0.79; 95% confidence interval [CI] = 0.61, 1.03). However, age-stratified analyses indicated a significant reduction in opioid positivity for drivers aged 21 to 40 years (OR = 0.50; 95% CI = 0.37, 0.67; interaction P < .001). Conclusions. Operational MMLs are associated with reductions in opioid positivity among 21-to 40-year-old fatally injured drivers and may reduce opioid use and overdose.

Original languageEnglish (US)
Pages (from-to)2032-2037
Number of pages6
JournalAmerican Journal of Public Health
Volume106
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Medical Marijuana
Opioid Analgesics
Odds Ratio
Confidence Intervals
Information Systems
Research Design
Alcohols
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers. / Kim, June H.; Santaella-Tenorio, Julian; Mauro, Christine; Wrobel, Julia; Cerda, Magdalena; Keyes, Katherine M.; Hasin, Deborah; Martins, Silvia S.; Li, Guohua.

In: American Journal of Public Health, Vol. 106, No. 11, 01.11.2016, p. 2032-2037.

Research output: Contribution to journalReview article

Kim, JH, Santaella-Tenorio, J, Mauro, C, Wrobel, J, Cerda, M, Keyes, KM, Hasin, D, Martins, SS & Li, G 2016, 'State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers', American Journal of Public Health, vol. 106, no. 11, pp. 2032-2037. https://doi.org/10.2105/AJPH.2016.303426
Kim, June H. ; Santaella-Tenorio, Julian ; Mauro, Christine ; Wrobel, Julia ; Cerda, Magdalena ; Keyes, Katherine M. ; Hasin, Deborah ; Martins, Silvia S. ; Li, Guohua. / State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers. In: American Journal of Public Health. 2016 ; Vol. 106, No. 11. pp. 2032-2037.
@article{a8ed28883446429fb2f50c22d7561df1,
title = "State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers",
abstract = "Objectives. To assess the association between medical marijuana laws (MMLs) and the odds of a positive opioid test, an indicator for prior use. Methods. We analyzed 1999-2013 Fatality Analysis Reporting System (FARS) data from 18 states that tested for alcohol and other drugs in at least 80{\%} of drivers who died within 1 hour of crashing (n = 68 394). Within-state and between-state comparisons assessed opioid positivity among drivers crashing in states with an operational MML (i.e., allowances for home cultivation or active dispensaries) versus drivers crashing in states before a future MML was operational. Results. State-specific estimates indicated a reduction in opioid positivity for most states after implementation of an operational MML, although none of these estimates were significant. When we combined states, we observed no significant overall association (odds ratio [OR] = 0.79; 95{\%} confidence interval [CI] = 0.61, 1.03). However, age-stratified analyses indicated a significant reduction in opioid positivity for drivers aged 21 to 40 years (OR = 0.50; 95{\%} CI = 0.37, 0.67; interaction P < .001). Conclusions. Operational MMLs are associated with reductions in opioid positivity among 21-to 40-year-old fatally injured drivers and may reduce opioid use and overdose.",
author = "Kim, {June H.} and Julian Santaella-Tenorio and Christine Mauro and Julia Wrobel and Magdalena Cerda and Keyes, {Katherine M.} and Deborah Hasin and Martins, {Silvia S.} and Guohua Li",
year = "2016",
month = "11",
day = "1",
doi = "10.2105/AJPH.2016.303426",
language = "English (US)",
volume = "106",
pages = "2032--2037",
journal = "American Journal of Public Health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
number = "11",

}

TY - JOUR

T1 - State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers

AU - Kim, June H.

AU - Santaella-Tenorio, Julian

AU - Mauro, Christine

AU - Wrobel, Julia

AU - Cerda, Magdalena

AU - Keyes, Katherine M.

AU - Hasin, Deborah

AU - Martins, Silvia S.

AU - Li, Guohua

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Objectives. To assess the association between medical marijuana laws (MMLs) and the odds of a positive opioid test, an indicator for prior use. Methods. We analyzed 1999-2013 Fatality Analysis Reporting System (FARS) data from 18 states that tested for alcohol and other drugs in at least 80% of drivers who died within 1 hour of crashing (n = 68 394). Within-state and between-state comparisons assessed opioid positivity among drivers crashing in states with an operational MML (i.e., allowances for home cultivation or active dispensaries) versus drivers crashing in states before a future MML was operational. Results. State-specific estimates indicated a reduction in opioid positivity for most states after implementation of an operational MML, although none of these estimates were significant. When we combined states, we observed no significant overall association (odds ratio [OR] = 0.79; 95% confidence interval [CI] = 0.61, 1.03). However, age-stratified analyses indicated a significant reduction in opioid positivity for drivers aged 21 to 40 years (OR = 0.50; 95% CI = 0.37, 0.67; interaction P < .001). Conclusions. Operational MMLs are associated with reductions in opioid positivity among 21-to 40-year-old fatally injured drivers and may reduce opioid use and overdose.

AB - Objectives. To assess the association between medical marijuana laws (MMLs) and the odds of a positive opioid test, an indicator for prior use. Methods. We analyzed 1999-2013 Fatality Analysis Reporting System (FARS) data from 18 states that tested for alcohol and other drugs in at least 80% of drivers who died within 1 hour of crashing (n = 68 394). Within-state and between-state comparisons assessed opioid positivity among drivers crashing in states with an operational MML (i.e., allowances for home cultivation or active dispensaries) versus drivers crashing in states before a future MML was operational. Results. State-specific estimates indicated a reduction in opioid positivity for most states after implementation of an operational MML, although none of these estimates were significant. When we combined states, we observed no significant overall association (odds ratio [OR] = 0.79; 95% confidence interval [CI] = 0.61, 1.03). However, age-stratified analyses indicated a significant reduction in opioid positivity for drivers aged 21 to 40 years (OR = 0.50; 95% CI = 0.37, 0.67; interaction P < .001). Conclusions. Operational MMLs are associated with reductions in opioid positivity among 21-to 40-year-old fatally injured drivers and may reduce opioid use and overdose.

UR - http://www.scopus.com/inward/record.url?scp=84990831628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990831628&partnerID=8YFLogxK

U2 - 10.2105/AJPH.2016.303426

DO - 10.2105/AJPH.2016.303426

M3 - Review article

C2 - 27631755

AN - SCOPUS:84990831628

VL - 106

SP - 2032

EP - 2037

JO - American Journal of Public Health

JF - American Journal of Public Health

SN - 0090-0036

IS - 11

ER -